Contract liabilities	12 Months Ended
Dec. 31, 2024
Contract liabilities [abstract]
Schedule of Revenue Attributable to Commercial Customers	Note 14—Contract Liabilities At December 31, 2024, contract liabilities comprise unsatisfied performance obligations related to delivery of commercial supply under one of the Company’s license agreements. Non-current contract liabilities are expected to be recognized as revenue within 1-2 years. Revenue recognized from contract liabilities were €1.4 million, €13.3 million and €10.5 million for the years ended December 31, 2024, 2023 and 2022, respectively, and primarily related to delivery of clinical supply and research and development services.

The entire disclosure for revenue from contracts with customers.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2024-01-01
-Section Presentation
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI
-URIDate 2024-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2024-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI
-URIDate 2024-03-27

Name:	ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration